Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19102746 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria
Condition: Malaria, Falciparum
Interventions: Drug: Artemether/lumefantrine tablets;   Drug: Artemether/Lumefantrine suspension

Indicates status has not been verified in more than two years